Anti – CTLA-4 monoclonal antibody, tumor growth in the case of over-expressing certain types of cancer, tumors self proteins inhibit substantially hiding the tumor from the immune system http://anafranil.org/clomipramine-for-cats . Aida Pharmaceuticals is in the developmental stages of the anti-CTLA-4 monoclonal antibodies, the inhibition of T – cells so that they become identify the overexpressed proteins and, in turn, of course, attack the cancer cells without can alleviate healthy tissue.
About Aida Pharmaceuticals:.Aida Pharmaceuticals is a product-focused pharmaceutical company engaged in the formulation, dedicated clinical testing, registration, manufacture, sale and marketing of advanced pharmaceutical and gene products in the People Republic of China The mission of the company is to discover and market products and commercialize a resident meaningful new therapies that improve human health. Operating since March 1999 in Hangzhou, China with manufacturing, distribution and sales outlets throughout China. Aida is GMP certified in China and ISO9002 certified for and ISO14000 and ISO14000 for environmental practices certified. Aida is now producing and marketing a patented prescription drug in China, Etimicin Sulfate. This is the first antibiotic developed in China and is a category ‘A’drug by the State Food and Drug Administration of China viewed. Safe Harbor Statement:.
U.S. Food and Drug azacitidine is admit Fast Track Designation for myelodysplastic syndromes.